Listen on the go
CORRECT!
Next question
touchNEUROLOGY touchNEUROLOGY

Start Learning

Touch Loading image
A digital rendering of a human brain with highlighted neural pathways and electric activity, visualizing brain function.
JOURNALS
Start Learning
Amyotrophic Lateral Sclerosis: A Review of Aetiopathogenetic Insights
JOURNALS
Start Learning
Foreword: touchREVIEWS in Neurology, Volume 20, Issue 2, 2024
JOURNALS
Start Learning
Mapping a legacy in epilepsy: The career journey of Prof. Ruben Kuzniecky
touchIN CONVERSATION
Start Learning
Let’s talk about agitation in Alzheimer’s dementia: Prevalence, behavioural symptoms and reaching a diagnosis
CE/CME ACCREDITED
touchFEATURE
Start Learning
Streamlining Alzheimer’s disease diagnosis: The evolution of fluid biomarkers in clinical practice
Sponsored content
touchFEATURE
Start Learning
Friedreich ataxia – from genetic mutations to clinical symptoms
Sponsored content
touchPANEL DISCUSSION
Start Learning
Pharmacological management of agitation in Alzheimer’s dementia: Rationale and evidence for new and emerging treatment options
CE/CME ACCREDITED
A digital rendering of a human brain with highlighted neural pathways and electric activity, visualizing brain function.
JOURNALS
Start Learning
Experiences of lecanemab in a clinical setting: An interview with Dr Andy Liu #ADPD2025
JOURNALS
Start Learning
Nipocalimab for generalized myasthenia gravis: First FcRn blocker approved for broad adult population
JOURNALS
Start Learning
Prenatal treatment for SMA shows promise in groundbreaking case report

to view Favourites, Keep Notes and Track CME Credits

Favourites
Early diagnosis and treatment of NMOSD: Practical insights
View
Supporting Brain Awareness Week 2025: Advancing knowledge in brain science
View
The future of brain science: Interview with Dr Hannah Critchlow – touchNEUROLOGY Future Leader 2025
View
Individualized myasthenia gravis treatment based on well-defined disease pathogenesis
View
The potential of BTKi therapies in delaying MS progression
View
Perspectives on psychiatric care with Dr Anna Laure: touchNEUROLOGY Future Leader 2025
View
Anti-CGRP therapies improve migraine control and adherence
View
Pharmacological management of agitation in Alzheimer’s dementia: Rationale and evidence for new and emerging treatment options
View
Tenecteplase receives FDA approval for acute ischemic stroke
View
Movement disorders at EAN 2024: Key highlights and beyond
View
Copied to clipboard!
accredited arrow-down-editablearrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-red tick-whiteticktimetranscriptup-arrowwebinar Sponsored Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72
Close Popup